AstraZeneca Covid Vaccine Up to 79% Effective, Trial Results in the US

Oxford and AstraZeneca Covid Vaccine are up to 79 percent effective against the Coronavirus. This has been revealed in the trial of this vaccine in America. The Vaccine in the trial has helped in the prevention of fever and other serious illnesses.

Vaccine trial conducted on 30 thousand people

The UK drugmaker published the data on the successful and safe trial of this Covid Vaccine on 30 thousand volunteers on Monday. It was told that the vaccine proved to be very effective on aged people.

A quarter of the volunteers involved in the vaccine trial were over 65 years of age. Earlier, a conclusive data could not be found in the study conducted last year due to non-inclusion of people above 65 years of age.

Questions were raised on the vaccine due to blood clotting

A few days ago, after the use of this vaccine, questions were raised on the reliability of the vaccine when cases of blood clotting came to light. After this, the use of this Covid Vaccine was banned in many countries of Europe.

However, AstraZeneca has said that in the tests conducted in the US, the committee has done a special review on the investigation of blood clotting. With the help of neurologists, there was no case of blood clotting in the brain.

The drug manufacturer said that the first dose of the vaccine given to 21,583 people did not see any effect related to thrombosis or related to it.

Bio-pharmaceuticals official said that, this test will increase the reliability of the vaccine and it will prove to be very effective in protecting against Covid-19. We believe that the vaccine will help protect people worldwide from the corona virus.